Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer

por Igawa, Satoshi, Ono, Taihei, Kasajima, Masashi, Manabe, Hideaki, Fukui, Tomoya, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2020

Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer

por Fukui, Tomoya, Ishihara, Mikiko, Kasajima, Masashi, Hiyoshi, Yasuhiro, Nakahara, Yoshiro, Otani, Sakiko, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2019

A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer

por Igawa, Satoshi, Kasajima, Masashi, Ono, Taihei, Ozawa, Takahiro, Kakegawa, Mikiko, Kusuhara, Seiichiro, Sato, Takashi, Nakahara, Yoshiro, Fukui, Tomoya, Yokoba, Masanori, Kubota, Masaru, Mitsufuji, Hisashi, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2021

The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated w...

por Akazawa, Yuki, Igawa, Satoshi, Yamada, Kaori, Yamamoto, Hiroki, Yagami, Yuri, Kaizuka, Nobuki, Manaka, Hiroya, Kasajima, Masashi, Nakahara, Yoshiro, Sato, Takashi, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2023

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

por Shirasawa, Masayuki, Fukui, Tomoya, Kusuhara, Seiichiro, Hiyoshi, Yasuhiro, Ishihara, Mikiko, Kasajima, Masashi, Nakahara, Yoshiro, Otani, Sakiko, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018

Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma

por Nakahara, Yoshiro, Fukui, Tomoya, Shirasawa, Masayuki, Harada, Shinya, Kusuhara, Seiichiro, Takakura, Akira, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Masuda, Noriyuki, Inukai, Madoka, Sekiguchi, Tomoko, Naoki, Katsuhiko
Publicado 2018

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer

por Shirasawa, Masayuki, Fukui, Tomoya, Kusuhara, Seiichiro, Harada, Shinya, Nishinarita, Noriko, Hiyoshi, Yasuhiro, Ishihara, Mikiko, Kasajima, Masashi, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2019

Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status

por Igawa, Satoshi, Shirasawa, Masayuki, Ozawa, Takahiro, Nishinarita, Noriko, Okuma, Yuriko, Ono, Taihei, Sugimoto, Ai, Kurahayashi, Shintaro, Sugita, Keisuke, Sone, Hideyuki, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018

Amrubicin monotherapy for elderly patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective study

por Sone, Hideyuki, Igawa, Satoshi, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Hosotani, Shinji, Ohe, Shuntaro, Ito, Hiroki, Kaizuka, Nobuki, Manaka, Hiroya, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018

Multicenter study of zoledronic acid administration in non-small-cell lung cancer patients with bone metastasis: Thoracic Oncology Research Group (TORG) 1017

por Nakahara, Yoshiro, Hosomi, Yukio, Shibuya, Masahiko, Mitsufuji, Hisashi, Katagiri, Masato, Naoki, Katsuhiko, Soejima, Kenzo, Nogami, Naoyuki, Nagase, Seisuke, Nishikawa, Masanori, Minato, Koichi, Takiguchi, Yuichi, Seki, Nobuhiko, Yamada, Kouzo, Seto, Takashi, Okamoto, Hiroaki
Publicado 2019

Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non‐small cell lung cancer prior to the approval of durvalumab

por Fukui, Tomoya, Hosotani, Shinji, Soda, Itaru, Ozawa, Takahiro, Kusuhara, Seiichiro, Kakegawa, Mikiko I., Kasajima, Masashi, Hiyoshi, Yasuhiro, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Ishiyama, Hiromichi, Naoki, Katsuhiko
Publicado 2020

Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease

por Igawa, Satoshi, Nishinarita, Noriko, Takakura, Akira, Ozawa, Takahiro, Harada, Shinya, Kusuhara, Seiichiro, Niwa, Hideyuki, Hosotani, Shinji, Sone, Hideyuki, Nakahara, Yoshiro, Fukui, Tomoya, Mitsufuji, Hisashi, Yokoba, Masanori, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018